Researchers from institutions across the U.S. evaluated data from the Organ Preservation in Rectal Adenocarcinoma trial of 277 rectal cancer patients from April 2014 to March 2020.

Rectal cancer is relatively common, with about 46,220 new cases diagnosed in the United States each year (27,330 in men and 18,890 in women), according to the American Cancer Society.

In total, they reviewed outcomes from 277 patients, with an average age of 58, who had the stage of their rectal cancer determined by MRI. The average length of the follow-up period was slightly ...

In total, they reviewed outcomes from 277 patients, with an average age of 58, who had the stage of their rectal cancer determined by MRI. The average length of the follow-up period was slightly ...

In total, they reviewed outcomes from 277 patients, with an average age of 58, who had the stage of their rectal cancer determined by MRI. The average length of the follow-up period was slightly ...

Key Takeaways NG-350A is an innovative immunotherapy designed to enhance immune response by targeting primary and metastatic tumor sites in rectal cancer. The FORTRESS trial combines NG-350A with ...

TOPLINE: In patients with locally advanced rectal cancer who receive neoadjuvant therapy, radiation dose intensification improves pathologic complete response but leads to a small increase in ...

The median follow-up for all patients was 61 months. (2) The five-year local recurrence-free survival rate for the ISR-CAA group was 79%, significantly lower than 93% for the APR group (p=0.038).

Join Drs Benjamin Schlechter and Joshua Smith as they discuss the evolution of nonoperative rectal cancer management and organ preservation, highlighting groundbreaking trials like OPRA and JANUS.

A total of 117 patients were included in the analysis. In cohort 1, all 49 patients who completed treatment had a clinical complete response and elected to proceed with nonoperative management. A ...

Rectal cancer is relatively common, with about 46,220 new cases diagnosed in the United States each year (27,330 in men and 18,890 in women), according to the American Cancer Society.